The Biopharmaceutical Excipients Market Size was valued at USD 2.37 billion in 2022, and is expected to reach USD 3.96 billion by 2030 and grow at a CAGR of 6.6% over the forecast period 2023-2030. Several key factors are propelling this market growth: Soaring demand for biologics: The rise of complex biopharmaceuticals like antibodies and gene therapies, with unique...

The Toxoid Vaccine Market size was worth US$ 5.61 billion in 2022 and is estimated to reach US$ 8.22 billion by 2030, growing at a CAGR of 4.9% during the forecast period 2023-2030. Several key factors are propelling this market growth: Rising Immunization Rates: Increased emphasis on global vaccination programs, particularly in developing countries, drives demand for...